Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2531226011 | Abacavir 600mg/lamivudine 300mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2534731013 | Abacavir 600mg/lamivudine 300mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2553556015 | Abacavir 600mg / lamivudine 300mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3486918018 | Product containing abacavir 600 mg and lamivudine 300 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3495315016 | Product containing abacavir 600 mg and lamivudine 300 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3501987012 | Abacavir 600 mg and lamivudine 300 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570070013 | Product containing only abacavir 600 mg and lamivudine 300 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3570071012 | Product containing only abacavir 600 mg and lamivudine 300 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676205019 | Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3676206018 | Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing abacavir and lamivudine (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Abacavir (substance) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Is a | Product containing abacavir and lamivudine in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Lamivudine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 300 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has active ingredient | Abacavir (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Abacavir (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 600 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Abacavir (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Has precise active ingredient | Lamivudine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet | Is a | Abacavir and lamivudine only product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR